The Australian Imaging Biomarkers and Lifestyle

Slides:



Advertisements
Similar presentations
1 Unit 1 Hello!. Alice Su Nan Kitty Wu Chen Colin Kevin.
Advertisements

Group Personal Assistants Julie Golding, Marie Smith, Wendy Roe Head of Professional Services Beverley Jones Environmental Health Service Manager Vacant.
FY14 UK Sales Territory Alignment
Legal, Democratic and Procurement Services
The Australian Imaging Biomarkers and Lifestyle Flagship Study of Ageing AUSTRALIAN ADNI. July 2010 UPDATE.
December, NEED FOR VALIDATED BIOMARKERS FOR AD TRIALS Biomarkers useful in Phase 2 to make decisions about Phase 3 (e.g. doses) Biomarkers useful.
DIAN Treatment Trials An Update Sunday February 10, :00 to 6:00 PM CST Presented by Randall Bateman MD DIAN Therapeutic Trials Unit Director DIAN.
College of Engineering, Mathematics and Physical Sciences.
Alzheimer’s Disease Neuroimaging Initiative STEERING COMMITTEE April
ADNI 3 Clinical Core Plans
Welcome to the NEW BRIGHTON RUGBY FOOTBALL CLUB PRIZEGIVING.
EPAD update José Luis Molinuevo Worldwide-ADNI Update Meeting Friday, July 17, 2015 Washington, D.C.
Dept. of Radiology, Xuanwu Hospital, Capital Medical University Beijing: Emeil: 首都 Update of China-ADNI Kuncheng Li.
©2012 MFMER | ADNI Clinical Core Paul Aisen Ron Petersen Michael Donohue Jennifer Salazar.
Alzheimer’s disease Platforms for translational research.
Update Arg-ADNI Gustavo E. Sevlever, Ricardo F. Allegri (*), Silvia Vázquez, Deborah R. Gustafson, Salvador M. Guinjoan, and Arg-ADNI group. Memory and.
Professor David Ames BA, MD, FRCPsych, FRANZCP University of Melbourne Professor of Ageing and Health Director National Ageing Research Institute Co-leader.
CARMA Established fall 1997 Devoted to continuing education in various areas of research methods and data analysis relevant to the social and organizational.
CS Ltd Board Ed Monaghan (Chair) George Bell Derek Shewan Newell McGuinness Industry Leadership Group Ed MonaghanMartin English Alastair Wallace David.
The Australian Imaging Biomarkers and Lifestyle Flagship Study of Ageing (AUSTRALIAN ADNI). July 2015 UPDATE Christopher Rowe MD – Neuroimaging stream.
©2012 MFMER | ADNI Clinical Core Paul Aisen Ron Petersen Michael Donohue Jennifer Salazar ADNI Steering Committee Meeting Washington, DC April.
1 陕西旅游出版社三年级上册 Unit 1 Hello!. 人物表 Alice Su Nan Kitty Wu Chen Colin Kevin.
Welcome to HEDGE END RUNNING CLUB Celebration Evening 2015 The Winners!
Corporate Management Team Ged Curran Chief Executive Yvette Stanley Director of Children, Schools & Families Caroline Holland Director of Corporate Services.
Comic Book Assignments For both B and E Block. B Block Chapters Student Kristen Stephanie Robert Chris.
H.W.Greenham & Sons MURRAY FOOTBALL LEAGUE ROUND 1.
Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging Christopher C. Rowe, Kathryn A. Ellis, Miroslava Rimajova,
H.W.Greenham & Sons MURRAY FOOTBALL LEAGUE ROUND 1.
Dove Elevated Storage Tank CISD Logo Addition. Thank you to the following donors Shady Oaks Development - $1,500 Shady Oaks Development - $1,500 Paul.
Update of China-ADNI Kuncheng Li, MD. PhD.
ADNI3 Clinical core Paul Aisen Ron Petersen Mike Donohue
José L Molinuevo, Craig Ritchie, Miia Kivipelto
Enron Europe Legal Department Structure Chart
The Australian Imaging, Biomarkers and Lifestyle Study of Aging
Alzheimer’s Disease Neuroimaging Initiative 3 (ADNI 3)
Presenter: Dr. Patricio Chrem
Estates & Capital Development Organisation Chart
Localization of Hippocampal atrophy in Alzheimer's disease
Estates & Capital Development Organisation Chart
COULTHARD MEDAL PRESENTATION
HILLSBOROUGH Football Disaster
A multinational study distinguishing Alzheimer's and healthy patients using cerebrospinal fluid tau/Aβ42 cutoff with concordance to amyloid positron emission.
Emma Bird, Jenna Panter, Graham Baker, Tim Jones, David Ogilvie
Table 2. Data Sharing for (Reporting Period)
Volume 2, Issue 1, Pages (January 2016)
Imaging AD Progression Amyloid Imaging Agents.
DIET, NEUROIMAGING BIOMARKERS AND ALZHEIMER’S DISEASE: DATA FROM THE AUSTRALIAN IMAGING, BIOMARKERS AND LIFESTYLE STUDY OF AGEING Ralph N Martins, PhD.
Leslie M Shaw Perelman School of Medicine University of Pennsylvania
Staff Structure November 2017 CEO Sara Sutcliffe
PPMI Beyond 2018.
人名昵稱簡稱 Pet Names 伍德基 T. K. NG.
Repositories Lunch Meeting, Day 1
PPMI – GOALS 2019 Ken Marek PPMI Annual Meeting May 3, 2018
ADNI3 Clinical core Paul Aisen Ron Petersen Mike Donohue
José L Molinuevo, Craig Ritchie, Miia Kivipelto
ADNI Clinical Core Paul Aisen Ron Petersen Michael Donohue
Ron Petersen & Paul Aisen
Presenter: Dr. Patricio Chrem
Estates & Capital Development Organisation Chart
Update of China-ADNI Kuncheng Li, MD. PhD.
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker.
The Australian Imaging Biomarkers and Lifestyle
Argentina Arg-ADNI Ezequiel Surace, PhD.
Children and Younger Adults Department
Personalized Medicine in Psychiatry
Clifford R. Jack, Heather J. Wiste, Stephen D. Weigand, Terry M
MR-less cortical surface-projection of PET images from 11C- and 18F-labeled radiotracers  Vincent Doré, Pierrick Bourgeat, Luping Zhou, Jurgen Fripp,
Plasma Amyloid β42 and Amyloid β40 Levels Are Associated With Early Cognitive Dysfunction After Cardiac Surgery  Lisbeth A. Evered, BS, MBiostat, Brendan.
Michael Navitsky, Abhinay D. Joshi, Michael D. Devous, Michael J
Figure 2 Aβ-PET scans obtained using different tracers
Presentation transcript:

The Australian Imaging Biomarkers and Lifestyle . The Australian Imaging Biomarkers and Lifestyle Flagship Study of Ageing Commenced 2006 PiB and MRI with follow-up in 288 of the 1100 original participants. Imaging increased since to 1,515 of 2,135 participants

Progress Baseline assessment in 2135 subjects with MRI and amyloid PET in 75%. Added 420 HC from A4 screening. Added 220 MCI/Mild AD (MMSE >20) from clinical trials screening. Just started 10.5 year review cycle Amyloid PET and MRI at 0, 18, 38 months then every 3 years Tau PET ? 250 done but still evaluating best tracer to use CSF in 250 subjects but not serial

Progress Releasing 6 year time point scans on LONI/ADNI/AIBL website this month. Adding amyloid scan classification to AIBL data on GAAIN. Adding florbetaben conversion to centiloid scans and data to GAAIN this month.

Current Focus Converting all amyloid results to centiloid units and will revisit previous analyses with larger sample size Quest for a blood biomarker continues internally and via supply of samples to many academic and commercial groups Moving to more formal pooling of data with other large cohorts (academic and commercial initiatives) Supporting clinical drug trials in preclinical and prodromal AD and aiming to move this to a wider national platform Evaluating tau tracers Genetic and lifestyle analysis continues Supporting retinal scans (multispectral; curcumin)

Problems Losing many amyloid positive participants to drug trials Reliant on commercial and philanthropic support

Expression of interest for collaboration or more in-depth data access should go to: Christopher Fowler - AIBL Co-ordinator christopher.fowler@florey.edu.au

Acknowledgements AIBL would like to thank the study participants and their families AIBL Study team David Ames Jenalle Baker Mary Barnes Kevin Barnham Shayne Bellingham Sabine Bird Julia Bomke Pierrick Bourgeat Sveltana Bozinovski (nee Pejoska) Belinda Brown Rachel Buckley Samantha Burnham Ashley Bush Lesley Cheng Steven Collins Ian Cooke Elizabeth Cyarto David Darby James Doecke Vincent Dore Denise El-Sheikh Michael Fenech Shane Fernandez Binosha Fernando Christopher Fowler Maxime Francois Jurgen Fripp Shaun Frost Sam Gardener Simon Gibson Veer Gupta David Hanson Karra Harrington Andy Hill Eugene Hone Maryam Hor Gareth Jones Adrian Kamer Yogi Kanagasingam Fiona Lamb Nicola Lautenschlager Simon Laws Wayne Leifert Hugo Leroux Qiao-Xin Li Yen Ying Lim Florence Lim Lucy Lim Linda Lockett Andrea Louey Kathy Lucas Lance Macaulay Lucy Mackintosh Ralph Martins Georgia Martins Paul Maruff Colin Masters Simon McBride Alissandra Mcilroy Steve Pedrini Kayla Perez Kelly Pertile Tenielle Porter Stephanie Rainey-Smith Carolina Restrepo Malcolm Riley Blaine Roberts Jo Robertson Mark Rodrigues Christopher Rowe Rebecca Rumble Tim Ryan Olivier Salvado Ian Saunders Greg Savage KaiKai Shen Brendan Silbert Harmid Sohrabi Kevin Taddei Tania Taddei Sherilyn Tan Christine Thai Philip Thomas Brett Trounson Victor Villemagne Irene Volitakis Michael Vovos Larry Ward Andrew Watt Mike Weinborn Rob Williams Bill Wilson Michael Woodward Paul Yates Ping Zhang Collaborators AIBL is a large collaborative study and a complete list of contributors can be found at www.aibl.csiro.au